Abstract: A water level sensor (91) is provided in an auxiliary tank (39) whose bottom portion communicates to a bottom portion of a pot (41) for generating steam and which is opened to the atmosphere. When water in the pot (41) keeps boiling and the stop time of a pump (35) reaches a predetermined time (e.g., 60 sec.), the pump (35) is driven for a predetermined time (e.g., 6 sec.) to supply water to the pot (41). This temporarily suppresses the boiling of water in the pot (41), lowering a steam pressure in a space formed by an external circulation passage (60), a heating chamber, and the pot (41). The water level in the auxiliary tank (39) then returns to a normal one, making it possible to correctly detect the water level in the pot (41).

Abstract: An active matrix substrate includes a plurality of pixels arranged in a matrix, a plurality of capacitor lines (11b) extending in one of directions in which the pixels are aligned and in parallel to each other, a plurality of TFTs (5), one for each of the pixels, a protective film (16a) covering the TFTs (5), a plurality of pixel electrodes (18a) arranged in a matrix on the protective film (16a) and connected to the respective corresponding TFTs (5), and a plurality of auxiliary capacitors (6), one for each of the pixels. Each of the auxiliary capacitors (6) includes the corresponding capacitor line (11b), the corresponding pixel electrode (18a), and the protective film (16a) between the corresponding capacitor line (11b) and the corresponding pixel electrode (18a).

Abstract: The present invention is directed to substituted cyclopropyl imidazopyridine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: A display device equipped with a touch panel capable of correcting, with high precision, a line drawn upon the touch panel with an inclined touch pen or input member. A display device equipped with a touch panel includes a touch panel unit, a touch panel control unit, a pen incline information acquiring unit, a coordinate correction unit, and a display panel unit. The touch panel control unit detects a touch upon a touch panel surface, and acquires touch point coordinate information which is information for specifying a location which is touched on the touch panel surface. The pen incline information acquiring unit acquires pen or input member incline information, which is information relating to an angle which is formed by the touch pen and the touch panel surface when the touch pen and the touch panel face are in contact.

Abstract: The present invention relates to a cytomegalovirus (CMV) which has been recombinantly altered to express a heterologous polypeptide and to allow for external control of viral replication. The heterologous polypeptide may be a polypeptide of interest such as an antigen, antibody or immune modulator. The CMV vectors of the invention are replication defective, or chemically controllable replication capable, or replication competent. The present invention also relates to uses of the CMV vectors such as inducing an immune response to an antigen or expressing an antibody or immune modulator in vivo. Compositions comprising the CMV expressing the heterologous polypeptide are also encompassed by the present invention.

Abstract: This invention relates to tricyclic triazole compounds or their pharmaceutically acceptable salts. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the above-cited compounds or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.

Abstract: A light source device includes: a substrate having a front surface on which a light-emitting diode is mounted; and a case having a bottom plate that holds the substrate, wherein a driver circuit for driving the light-emitting diode is mounted on a rear surface of the substrate that is opposite to the front surface thereof, wherein an opening corresponding to a size of the light-emitting diode is formed in the bottom plate of the case, wherein the front surface of the substrate is fixed to a rear surface of the bottom plate of the case from outside of the case with the light-emitting diode fitted in the opening, and wherein a coating material with an emissivity of equal to or higher than 0.9 and equal to or lower than 1.0 is applied to an outer surface of four side walls of the case.

Abstract: Provided are methods of refolding and purifying lipoproteins on a chromatography column. In particular methods of refolding ApoL1 polypeptides using a hydrophobic interaction column (HIC). The present invention provides methods for the purification of an active form of a human lipoprotein, such as ApoL1. More particularly, the present invention relates to a method for renaturing an inclusion body of proteins expressed in a large quantity in E. coli into an active form using a hydrophobic interaction column and removal of impurities, e.g., endotoxins.

Abstract: A light-projecting device according to the present invention includes a plurality of light source units including (i) a light emitting section that emits light upon receiving a laser beam and (ii) a reflector. Each of the light source units project light to a corresponding one of light-projected spots which is a region to which light is projected in an illuminated region in a partitioning manner, and the illuminated region is formed by combining a plurality of the light-projected spot.

Abstract: Disclosed herein are compounds of Formula (I), wherein each of the substituents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the compound of Formula (I) and use of the compound in the treatment of neurodegenerative diseases or conditions such as Alzheimer's disease.

Abstract: A mobile station device that receives downlink control information which is used to selectively provide downlink scheduling or a random access order, on a physical downlink control channel from a base station device. The mobile station device also transmits a random access preamble using a random access channel to the base station device based on receiving the downlink control information which provides a random access order, where the downlink control information provides a downlink resource allocation in a case that the downlink control information is used to provide the downlink scheduling and where a preset value is set for a field of the downlink resource allocation in a case that the downlink control information is used to provide the random access order.

Abstract: The present invention is directed to pyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The present invention is directed to substituted cyclobutyl benzimidazole compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: A light projecting device of the present invention includes: a light source unit including (i) a laser element for emitting light, (ii) a light converging lens for converging the light emitted from the laser element, and (iii) a light emitting section for emitting light upon receipt of the light converged by the light converging lens; and a reflector for projecting light emitted from the light source unit. The light source unit is provided so as to be attached to or detached from a fixed part to which the light source unit is to be fixed.

Abstract: Thiazolidinone compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.

Abstract: An optical apparatus of an aspect of the present invention includes: a plurality of semiconductor laser elements each of which emits laser light; an optical fiber which has a core which guides the laser light; and an imaging section which causes a plurality of beams of laser light to form an image on an incidence end surface of the single core, the incidence end surface having an outer shape which has a first side defining a width of the core and a second side defining a height of the core, a plurality of spots which are formed on the incidence end surface having respective long axes which are aligned with each other, the long axes of the plurality of spots being aligned with the first side or the second side.

Abstract: In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to ?-amyloid (“A?”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (A?) protein, including Alzheimer's disease, are also disclosed.

Abstract: The storage section of the multifunction peripheral stores location information containing a storage location of software which transmits a control command whose execution is permissible. The execution permission judging section of the multifunction peripheral includes (I) a storage location detecting section which detects a storage location of software which has participated in a transmission of a received control command and (II) a command permitting/prohibiting section which (i) prohibits execution of the received control command when a storage location indicated by the location information is not detected by the storage location detecting section but (ii) permits execution of the received control command when the storage location is detected by the storage location detecting section.

Abstract: A light scanning device includes a plurality of light-emitting elements for scanning a scan object with respective light beams emitted from the respective light-emitting elements. The light scanning device includes secured sections, a first substrate, and a second substrate. To the secured sections, the respective light-emitting elements are secured. The first substrate includes a first connector. Mounting positions of the respective light-emitting elements to the first substrate are displaceable. The respective light-emitting elements are coupled to the first substrate. The second substrate includes a second connector coupled to the first connector. The first substrate and the second substrate are secured to a first specified position and a second specified position, respectively.

Abstract: A liquid crystal display device (1) according to one embodiment of the present invention includes a timing controller (4) which, (i) in a first display mode, in which a number of tones that each pixel is capable of displaying is smaller than a predetermined number, controls a scanning signal and a data signal by an interlace driving method, by which a single frame includes a plurality of fields, and (ii) in a second display mode, in which the number of tones that each pixel is capable of displaying is equal to or greater than the predetermined number, controls the scanning signal and the data signal by a progressive driving method.